VERA - Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.